Supply of 2.3 Million Syringes by March

Huons Supplies COVID-19 Vaccine Syringes to US Government View original image


[Asia Economy Reporter Kim Ji-hee] Huons announced on the 17th that HuonsUSA was recently selected as the supplier of 'COVID-19 vaccine syringes' for Seattle City, Washington State, USA, and has completed the delivery of the first batch.


The COVID-19 vaccine syringes supplied by Huons are minimum dead space (LDS) safety syringes from domestic company Shin-A Yanghaeng, delivered locally through Huons Group's US subsidiary HuonsUSA. HuonsUSA submitted samples of syringes from three domestic manufacturers upon request from the Washington State Hospital Association (WSHA). Among them, Shin-A Yanghaeng's syringes passed the final test and were selected as the official supplier.


Huons explained, "Along with the product quality of Shin-A Yanghaeng's LDS safety syringes, the trust built by HuonsUSA through stable and rapid supply of quarantine supplies to the Washington State government since last year led to the request from WSHA and the selection as a supplier."


The LDS safety syringes supplied by Huons were used at the Seattle Lumen Field Event Center, the largest public vaccination site in the United States. From the second batch onward, supplies will be extended to medical institutions in Washington State beyond Seattle City.


The LDS safety syringes are recommended by the US Centers for Disease Control and Prevention (CDC) for COVID-19 vaccination purposes. They have a safety feature that prevents users from being pricked by the needle after use, making them suitable for the US vaccination system, and they significantly reduce the leftover vaccine volume compared to regular syringes.


Huons expects the demand for LDS safety syringes recommended by the US CDC to increase rapidly as vaccination accelerates nationwide. Accordingly, 2.3 million syringes will be supplied within March, and more than 3.5 million units will be supplied monthly from April onward. Discussions for additional supply are also ongoing with various medical institutions and other regional governments in the US beyond Seattle City.



Um Ki-an, CEO of Huons, said, “We feel a sense of responsibility and mission that the LDS safety syringes supplied by Huons are being used at the largest public vaccination site in the US. We will supply the second batch requested by Seattle City and the quantities under discussion with medical institutions in Washington State as soon as possible to contribute to ending COVID-19.”


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing